Suppr超能文献

欧洲儿童、青少年和青年在新冠疫情之前及期间抗抑郁药使用情况的变化:一项系统评价

Change of antidepressant utilization in children, adolescents and young adults in Europe before and during the COVID-19 pandemic: a systematic review.

作者信息

Fassmer Alexander M, Wandscher Kathrin, Bedri Aida, Jobski Kathrin, Poustka Luise, Bachmann Christian J, Hoffmann Falk

机构信息

Department of Health Services Research, Division of Outpatient Care and Pharmacoepidemiology, Carl von Ossietzky Universität Oldenburg, Oldenburg, Lower Saxony, Germany.

Department of Health Services Research, Division of General Practice/Family Medicine, Carl von Ossietzky Universität Oldenburg, Oldenburg, Lower Saxony, Germany.

出版信息

Eur Child Adolesc Psychiatry. 2025 Aug 14. doi: 10.1007/s00787-025-02839-x.

Abstract

BACKGROUND

In recent decades, antidepressant utilization among young persons in Western countries has increased, raising concerns about overprescribing and safety. The COVID-19 pandemic and respective restrictions might have impacted not only youth's mental health but also antidepressant prescribing. Our aim was to systematically investigate changes in antidepressant utilization during the pandemic compared to pre-pandemic periods in European young persons.

METHODS

This systematic review was registered in PROSPERO (CRD42024559951). Observational studies with ≥ 100 European young persons (0-24 years) reporting prevalence or incidence data in antidepressant utilization before and during the pandemic (2018/2019 vs. 2021/2022) were included and percentage changes between two time periods calculated. MEDLINE (via PubMed), PsycINFO, and EMBASE were searched from January 1, 2021 to July 3, 2024 and supplemented by citation searching. Study quality was assessed using the Joanna Briggs Institute's tool.

FINDINGS

We screened 4,416 records for eligibility and included eight studies covering data from Austria, Denmark, Finland, France, Italy, Norway, Spain, and Sweden (n = 4 from Nordic countries). The number of included young persons ranged from 1071 to 3,455,521 and all studies used secondary data, mostly from registries. All studies showed a relative increase in overall antidepressant use during the COVID-19 pandemic, with variability between countries ranging from 23 to 52%. Antidepressant utilization showed higher increases in adolescents (n = 3 studies) and females (n = 3 studies). Selective serotonin reuptake inhibitors were more common (73.9-90.9%; n = 3 studies) than other antidepressant classes.

INTERPRETATION

During the COVID-19 pandemic, antidepressant utilization in young persons increased modestly in all studied European countries. This increase may mirror the surge in mental health problems in young persons during the pandemic, but may also reflect altered patterns of mental health services availability.

摘要

背景

近几十年来,西方国家年轻人中抗抑郁药的使用有所增加,引发了对过度开药和安全性的担忧。新冠疫情及其相关限制措施可能不仅影响了年轻人的心理健康,也影响了抗抑郁药的处方开具。我们的目的是系统地调查疫情期间欧洲年轻人抗抑郁药使用情况与疫情前相比的变化。

方法

本系统评价在PROSPERO(CRD42024559951)上进行了注册。纳入了对≥100名欧洲年轻人(0 - 24岁)进行的观察性研究,这些研究报告了疫情前和疫情期间(2018/2019年与2021/2022年)抗抑郁药使用的患病率或发病率数据,并计算了两个时间段之间的百分比变化。从2021年1月1日至2024年7月3日对MEDLINE(通过PubMed)、PsycINFO和EMBASE进行了检索,并通过引文检索进行补充。使用乔安娜·布里格斯研究所的工具评估研究质量。

结果

我们筛选了4416条记录以确定其是否符合纳入标准,纳入了八项研究,涵盖来自奥地利、丹麦、芬兰、法国、意大利、挪威、西班牙和瑞典的数据(北欧国家有4项)。纳入的年轻人数量从1071到3455521不等,所有研究均使用二手数据,主要来自登记处。所有研究均显示,在新冠疫情期间,总体抗抑郁药使用量相对增加,各国之间的变化幅度在23%至52%之间。抗抑郁药在青少年(3项研究)和女性(3项研究)中的使用量增加幅度更大。选择性5-羟色胺再摄取抑制剂比其他抗抑郁药类别更为常见(73.9 - 90.9%;3项研究)。

解读

在新冠疫情期间,所有研究的欧洲国家中年轻人的抗抑郁药使用量均有适度增加。这种增加可能反映了疫情期间年轻人心理健康问题的激增,但也可能反映了心理健康服务可及性模式的改变。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验